Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs PARENT.DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA PARENT.DRUGS GRANULES INDIA/
PARENT.DRUGS
 
P/E (TTM) x 26.4 -0.1 - View Chart
P/BV x 3.7 - - View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 GRANULES INDIA   PARENT.DRUGS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
PARENT.DRUGS
Mar-21
GRANULES INDIA/
PARENT.DRUGS
5-Yr Chart
Click to enlarge
High Rs3813 12,026.8%   
Low Rs2273 8,730.8%   
Sales per share (Unadj.) Rs186.44.1 4,568.4%  
Earnings per share (Unadj.) Rs21.3-40.8 -52.3%  
Cash flow per share (Unadj.) Rs29.0-35.0 -82.7%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs116.4-229.0 -50.8%  
Shares outstanding (eoy) m242.0429.82 811.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.60.7 230.8%   
Avg P/E ratio x14.2-0.1 -20,161.8%  
P/CF ratio (eoy) x10.5-0.1 -12,741.3%  
Price / Book Value ratio x2.60 -20,745.2%  
Dividend payout %7.00-   
Avg Mkt Cap Rs m73,61186 85,574.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4,203145 2,896.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,119122 37,080.2%  
Other income Rs m1431 22,323.4%   
Total revenues Rs m45,262122 37,006.0%   
Gross profit Rs m9,133-118 -7,757.7%  
Depreciation Rs m1,845173 1,064.8%   
Interest Rs m5591,254 44.6%   
Profit before tax Rs m6,872-1,545 -444.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,706-328 -520.7%   
Profit after tax Rs m5,166-1,217 -424.4%  
Gross profit margin %20.2-96.8 -20.9%  
Effective tax rate %24.821.2 117.0%   
Net profit margin %11.4-1,000.3 -1.1%  
BALANCE SHEET DATA
Current assets Rs m25,741681 3,781.5%   
Current liabilities Rs m18,13511,436 158.6%   
Net working cap to sales %16.9-8,839.3 -0.2%  
Current ratio x1.40.1 2,384.7%  
Inventory Days Days14375 3.9%  
Debtors Days Days770-  
Net fixed assets Rs m23,2903,343 696.7%   
Share capital Rs m242298 81.2%   
"Free" reserves Rs m27,927-7,127 -391.8%   
Net worth Rs m28,169-6,829 -412.5%   
Long term debt Rs m1,4861,072 138.7%   
Total assets Rs m49,0314,024 1,218.6%  
Interest coverage x13.3-0.2 -5,739.6%   
Debt to equity ratio x0.1-0.2 -33.6%  
Sales to assets ratio x0.90 3,043.0%   
Return on assets %11.70.9 1,261.8%  
Return on equity %18.317.8 102.9%  
Return on capital %25.15.0 496.8%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Exports (fob) Rs m36,526NA-   
Imports (cif) Rs m14,120NA-   
Fx inflow Rs m36,5260-   
Fx outflow Rs m14,1200-   
Net fx Rs m22,4060-   
CASH FLOW
From Operations Rs m7,3871,253 589.5%  
From Investments Rs m-1,9141 -308,650.0%  
From Financial Activity Rs m-4,403-1,254 351.0%  
Net Cashflow Rs m1,068-1 -209,496.1%  

Share Holding

Indian Promoters % 41.6 73.3 56.8%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 28.9 0.0 289,300.0%  
FIIs % 18.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 26.7 217.3%  
Shareholders   190,691 7,129 2,674.9%  
Pledged promoter(s) holding % 4.1 94.5 4.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs PARENT.DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs PARENT.DRUGS Share Price Performance

Period GRANULES INDIA PARENT.DRUGS S&P BSE HEALTHCARE
1-Day 0.03% 4.63% 1.18%
1-Month -6.51% 9.71% -0.75%
1-Year 58.65% -19.48% 61.82%
3-Year CAGR 11.62% 8.97% 18.16%
5-Year CAGR 29.84% -19.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the PARENT.DRUGS share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of PARENT.DRUGS the stake stands at 73.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of PARENT.DRUGS.

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

PARENT.DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of PARENT.DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.